Modified ecstasy '100 times more effective at killing certain cancer cells'

22 August 2011

Certain cancer cells can be effectively combated through modified forms of ecstasy, new cancer treatment research from the universities of Birmingham and Western Australia has found.

Previous studies have indicated that ecstasy, the common term for MDMA, had cancer beating properties but patients would have to be exposed to lethal levels of the drug for them to have any affect, reports Medical News Today.

However, modified analogues, or compounds, of MDMA developed by scientists at the University of Western Australia were applied to leukaemia, lymphoma and myeloma cancer cells and were found to kill the disease 100 times more effectively than unmodified ecstasy.

"By knowing this we can theoretically make even more potent analogues of MDMA and eventually reach a point where we will have in our drug cabinet the most potent form we could," explained lead author Professor John Gordon.

A recent paper presented to the American Society of Clinical Oncology in Chicago suggested that widely used herbal supplements among patients could actually be having an adverse affect on cancer battling procedures such as chemotherapy treatment and radiotherapy.

Posted by Jeanette Royston


1 Wasik AM, Gandy MN, et al., "Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death." Investigational New Drugs, Thursday August 18th 2011


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.
 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)